デフォルト表紙
市場調査レポート
商品コード
1750929

血小板の世界市場レポート 2025年

Blood Platelets Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.80円
血小板の世界市場レポート 2025年
出版日: 2025年06月17日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血小板の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.9%で87億9,000万米ドルに成長します。予測期間中の成長は、外傷症例の増加、血液バンク数の増加、同種輸血療法への嗜好の高まり、人口の高齢化、創傷治癒における血小板の必要性の高まりに起因すると考えられます。この期間に予想される主な動向には、自動血小板アフェレーシスシステムの開発、血小板保存技術の発展、血小板を豊富に含む血漿(PRP)療法、白血球還元血小板へのシフト、人工血小板代替物の出現、血小板障害の遺伝子編集、自動ドナースクリーニングなどがあります。

血液疾患の有病率の増加は、血小板市場の拡大を促進すると予想されます。血液疾患とは、赤血球、白血球、血小板、血漿などの血液の機能、産生、成分に影響を与える状態を指し、貧血、凝固障害、免疫系不全などの問題につながります。加齢に伴う骨髄機能の自然な低下により、高齢者は貧血、血小板減少症、凝固障害などの状態に陥りやすくなるためです。血小板は、血液凝固を調節し、過剰な出血を防ぎ、創傷治癒をサポートするため、血液疾患の治療において極めて重要です。例えば、2024年4月、オーストラリアに本部を置く非営利団体パース血液研究所は、血液凝固因子の不足により血液がうまく固まらない稀な遺伝性疾患である血友病と診断された人の数が、2021年の23万3,577人から2022年には25万7,146人に達したと報告しました。したがって、血液疾患の有病率の上昇が血小板市場の成長に大きく寄与しています。

血液血小板市場の主要企業は、保存期間を延長し、可用性を向上させ、輸血需要の増加に対応する血液センターを支援するために、血小板プーリングなどの革新的なソリューションの開発に注力しています。血小板プーリングは、複数の全血献血から得られた血小板を組み合わせて輸血用の単一血小板ユニットを作成し、血液供給管理における可用性、効率性、資源利用を改善するものです。例えば、2023年2月、米国の医療技術企業であるテルモ・ブラッド・アンド・セル・テクノロジーズは、米国食品医薬品局(FDA)の認可を受け、IMUGARD WB血小板プーリングセットを発売しました。この技術革新により、全血由来血小板の保存期間が5日から7日に延長され、輸血用血小板の利用可能性が向上します。また、需要増とドナー不足に対応するための代替血小板供給を提供し、血液センターが在庫管理を強化し、無駄を削減するのに役立ちます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の血小板PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界の血小板市場:成長率分析
  • 世界の血小板市場の実績:規模と成長, 2019-2024
  • 世界の血小板市場の予測:規模と成長, 2024-2029, 2034F
  • 世界の血小板総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の血小板市場:血小板タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 全血由来血小板
  • アフェレーシス由来血小板
  • 世界の血小板市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 血小板機能障害
  • 血友病
  • 血小板減少症
  • 周術期適応
  • 世界の血小板市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • 外来手術センター
  • 血液銀行
  • 調査室
  • 専門クリニック
  • がん治療センター
  • 外傷センター
  • その他のエンドユーザー
  • 世界の血小板市場、全血由来血小板、タイプ別サブセグメンテーション:実績と予測, 2019-2024, 2024-2029F, 2034F
  • 白血球除去全血血小板
  • 白血球除去全血血小板
  • 病原体除去全血血小板
  • 世界の血小板市場、アフェレーシス由来血小板、タイプ別サブセグメンテーション:実績と予測, 2019-2024, 2024-2029F, 2034F
  • 単一ドナーアフェレーシス血小板
  • 白血球除去アフェレーシス血小板
  • 病原体除去アフェレーシス血小板

第7章 地域別・国別分析

  • 世界の血小板市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の血小板市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 血小板市場:競合情勢
  • 血小板市場:企業プロファイル
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
    • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Baxter International Inc.
  • CSL Limited
  • Grifols S.A.
  • Terumo Corporation
  • American Red Cross
  • BioMarin Pharmaceutical Inc.
  • Miltenyi Biotec
  • Kedrion Biopharma Inc.
  • LFB Group
  • Bio Products Laboratory Limited
  • Sanquin
  • Macopharma
  • Biotest AG
  • Cerus Corporation
  • ADMA Biologics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 血小板市場2029:新たな機会を提供する国
  • 血小板市場2029:新たな機会を提供するセグメント
  • 血小板市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r34782

Blood platelets, also known as thrombocytes, are small, disc-shaped cell fragments found in the blood that play a crucial role in clot formation and wound healing. They prevent excessive bleeding by adhering to damaged blood vessel walls, aggregating with other platelets, and releasing clotting factors to stabilize the clot and prevent significant blood loss. Produced in the bone marrow, platelets are vital for hemostasis and blood vessel repair.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of platelets in the blood platelet market are whole blood-derived platelets and apheresis-derived platelets. Whole blood-derived platelets are obtained by separating platelets from a standard whole blood donation, often pooled from multiple donors for transfusion. These platelets are used for treating platelet function disorders, hemophilia, thrombocytopenia, and perioperative indications. The primary end-users of these platelets include hospitals, ambulatory surgical centers, blood banks, research laboratories, specialty clinics, cancer treatment centers, trauma centers, and others.

The blood platelets market research report is one of a series of new reports from The Business Research Company that provides blood platelets market statistics, including blood platelets industry global market size, regional shares, competitors with a blood platelets market share, detailed blood platelets market segments, market trends and opportunities, and any further data you may need to thrive in the blood platelets industry. This blood platelets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood platelets market size has grown strongly in recent years. It will grow from$6.27 billion in 2024 to $6.72 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to the increasing number of surgeries, the rising incidence of traumatic injuries, the 6.27% prevalence of autoimmune diseases, the growing incidence of chronic diseases, and the increasing prevalence of thrombocytopenia.

The blood platelets market size is expected to see strong growth in the next few years. It will grow to$8.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth during the forecast period can be attributed to the increasing number of trauma cases, the rise in the number of blood banks, a growing preference for allogeneic blood transfusion therapies, the aging population, and the increasing need for platelets in wound healing. Key trends expected during this period include the development of automated platelet apheresis systems, advancements in platelet storage technologies, platelet-rich plasma (PRP) therapies, a shift toward leukoreduced platelets, the emergence of artificial platelet substitutes, gene editing for platelet disorders, and automated donor screening.

The growing prevalence of blood disorders is expected to propel the expansion of the blood platelets market. Blood disorders refer to conditions that impact the function, production, or components of blood, including red blood cells, white blood cells, platelets, or plasma, leading to issues such as anemia, clotting disorders, or immune system deficiencies. The increasing prevalence of these disorders is largely due to the aging population, as the natural decline in bone marrow function with age makes older adults more vulnerable to conditions such as anemia, thrombocytopenia, and clotting disorders. Blood platelets are crucial in the treatment of blood disorders, as they regulate blood clotting, preventing excessive bleeding and supporting wound healing. For example, in April 2024, the Perth Blood Institute, a non-profit organization based in Australia, reported that the number of people diagnosed with hemophilia, a rare genetic disorder where blood doesn't clot properly due to a lack of clotting factors, reached 257,146 in 2022, up from 233,577 in 2021. Therefore, the rising prevalence of blood disorders is significantly contributing to the growth of the blood platelets market.

Major players in the blood platelet market are focusing on developing innovative solutions such as platelet pooling to extend shelf life, improve availability, and assist blood centers in meeting the increasing demand for transfusions. Platelet pooling involves combining platelets from multiple whole blood donations to create a single platelet unit for transfusion, thereby improving availability, efficiency, and resource utilization in blood supply management. For instance, in February 2023, Terumo Blood and Cell Technologies, a US-based medical technology company, launched the IMUGARD WB platelet pooling set after receiving U.S. Food and Drug Administration (FDA) clearance. This innovation extends the shelf life of whole blood-derived platelets from five to seven days, improving platelet availability for transfusion. It also offers an alternative platelet supply to address rising demand and donor shortages, helping blood centers enhance inventory management and reduce waste.

In December 2023, Sysmex Corporation, a Japan-based healthcare and diagnostics company, increased its stake in Megakaryon Corporation for an undisclosed amount. With this acquisition, Sysmex aims to accelerate the commercialization of high-quality, induced pluripotent stem (iPS) cell-derived platelets by utilizing Megakaryon's technology, strengthening synergies within the group, and advancing regenerative medicine through automation and quality control innovations. Megakaryon Corporation, a Japan-based biotechnology company, specializes in the production of iPS cell-derived platelets for safer and more sustainable blood transfusions.

Major players in the blood platelets market are Pfizer Inc., Johnson & Johnson, Bayer AG, Fresenius Kabi, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Grifols S.A., Terumo Corporation, American Red Cross, BioMarin Pharmaceutical Inc., Miltenyi Biotec, Kedrion Biopharma Inc., LFB Group, Bio Products Laboratory Limited, Sanquin, Macopharma, Biotest AG, Cerus Corporation, ADMA Biologics Inc., Octapharma AG, Kamada Ltd., and HemaCare.

North America was the largest region in the blood platelets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in blood platelets report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the blood platelets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood platelets market consists of sales of platelet apheresis kits, platelet storage systems, platelet-derived growth factors (PDGFs), platelet function analyzers and platelet transfusion services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Platelets Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood platelets market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood platelets ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood platelets market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Platelet Type: Whole Blood Derived Platelets; Apheresis Derived Platelets
  • 2) By Application: Platelet Function Disorder; Hemophilia; Thrombocytopenia; Perioperative Indication
  • 3) By End-Users: Hospitals; Ambulatory Surgical Centers; Blood Banks; Research Laboratories; Specialty Clinics, Cancer Treatment Center, Trauma Center, Other End Users
  • Subsegments:
  • 1) By Whole Blood Derived Platelets: Leukocyte-Reduced Whole Blood Platelets; Non-Leukocyte-Reduced Whole Blood Platelets; Pathogen-Reduced Whole Blood Platelets
  • 2) By Apheresis Derived Platelets: Single-Donor Apheresis Platelets; Leukocyte-Reduced Apheresis Platelets; Pathogen-Reduced Apheresis Platelets
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Bayer AG; Fresenius Kabi; Takeda Pharmaceutical Company Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood Platelets Market Characteristics

3. Blood Platelets Market Trends And Strategies

4. Blood Platelets Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Blood Platelets Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Blood Platelets PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Blood Platelets Market Growth Rate Analysis
  • 5.4. Global Blood Platelets Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Blood Platelets Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Blood Platelets Total Addressable Market (TAM)

6. Blood Platelets Market Segmentation

  • 6.1. Global Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Whole Blood Derived Platelets
  • Apheresis Derived Platelets
  • 6.2. Global Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Platelet Function Disorder
  • Hemophilia
  • Thrombocytopenia
  • Perioperative Indication
  • 6.3. Global Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Blood Banks
  • Research Laboratories
  • Specialty Clinics
  • Cancer Treatment Centers
  • Trauma Centers
  • Other End Users
  • 6.4. Global Blood Platelets Market, Sub-Segmentation Of Whole Blood Derived Platelets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Leukocyte-Reduced Whole Blood Platelets
  • Non-Leukocyte-Reduced Whole Blood Platelets
  • Pathogen-Reduced Whole Blood Platelets
  • 6.5. Global Blood Platelets Market, Sub-Segmentation Of Apheresis Derived Platelets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Donor Apheresis Platelets
  • Leukocyte-Reduced Apheresis Platelets
  • Pathogen-Reduced Apheresis Platelets

7. Blood Platelets Market Regional And Country Analysis

  • 7.1. Global Blood Platelets Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Blood Platelets Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood Platelets Market

  • 8.1. Asia-Pacific Blood Platelets Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood Platelets Market

  • 9.1. China Blood Platelets Market Overview
  • 9.2. China Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood Platelets Market

  • 10.1. India Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood Platelets Market

  • 11.1. Japan Blood Platelets Market Overview
  • 11.2. Japan Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood Platelets Market

  • 12.1. Australia Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood Platelets Market

  • 13.1. Indonesia Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood Platelets Market

  • 14.1. South Korea Blood Platelets Market Overview
  • 14.2. South Korea Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood Platelets Market

  • 15.1. Western Europe Blood Platelets Market Overview
  • 15.2. Western Europe Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood Platelets Market

  • 16.1. UK Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood Platelets Market

  • 17.1. Germany Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood Platelets Market

  • 18.1. France Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood Platelets Market

  • 19.1. Italy Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood Platelets Market

  • 20.1. Spain Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood Platelets Market

  • 21.1. Eastern Europe Blood Platelets Market Overview
  • 21.2. Eastern Europe Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood Platelets Market

  • 22.1. Russia Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood Platelets Market

  • 23.1. North America Blood Platelets Market Overview
  • 23.2. North America Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood Platelets Market

  • 24.1. USA Blood Platelets Market Overview
  • 24.2. USA Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood Platelets Market

  • 25.1. Canada Blood Platelets Market Overview
  • 25.2. Canada Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood Platelets Market

  • 26.1. South America Blood Platelets Market Overview
  • 26.2. South America Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood Platelets Market

  • 27.1. Brazil Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood Platelets Market

  • 28.1. Middle East Blood Platelets Market Overview
  • 28.2. Middle East Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood Platelets Market

  • 29.1. Africa Blood Platelets Market Overview
  • 29.2. Africa Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood Platelets Market Competitive Landscape And Company Profiles

  • 30.1. Blood Platelets Market Competitive Landscape
  • 30.2. Blood Platelets Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

31. Blood Platelets Market Other Major And Innovative Companies

  • 31.1. Baxter International Inc.
  • 31.2. CSL Limited
  • 31.3. Grifols S.A.
  • 31.4. Terumo Corporation
  • 31.5. American Red Cross
  • 31.6. BioMarin Pharmaceutical Inc.
  • 31.7. Miltenyi Biotec
  • 31.8. Kedrion Biopharma Inc.
  • 31.9. LFB Group
  • 31.10. Bio Products Laboratory Limited
  • 31.11. Sanquin
  • 31.12. Macopharma
  • 31.13. Biotest AG
  • 31.14. Cerus Corporation
  • 31.15. ADMA Biologics Inc.

32. Global Blood Platelets Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Platelets Market

34. Recent Developments In The Blood Platelets Market

35. Blood Platelets Market High Potential Countries, Segments and Strategies

  • 35.1 Blood Platelets Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Blood Platelets Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Blood Platelets Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250617_r34782_Blood_Platelets_GMR_2025